Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Clarke

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Translational Medicine|May 13, 2020
Keynote 42: Pembrolizumab, PD-L1, and where to draw the lineJames Isaacs, Jeffrey Clarke, Neal Ready
Current Oncology Reports|August 3, 2021
Immune Checkpoint Inhibitors in the AgedJames Isaacs, Scott Antonia, Jeffrey Clarke
The American Journal of Case Reports|August 1, 2017
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two CasesArmando Bedoya, Kristen Glisinski, Jeffrey Clarke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2020
<i>APOB</i> Genotypes and <i>CDH13</i> Haplotypes in the Cholesterol-Related Pathway Genes Predict Non-Small Cell Lung Cancer SurvivalWei Deng, Hongliang Liu, Sheng Luo, et al.
Journal of Environmental Radioactivity|May 26, 2024
Neighborhood-level socioeconomic disparities in Radon testing in North Carolina from 2010 to 2020Zhenchun Yang, Lauren Prox, Clare Meernik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2022
Accuracy and clinical relevance of an automated, algorithm-based analysis of facial signs from selfie images of women in the United States of various ages, ancestries and phototypes: A cross-sectional observational studyFrederic Flament, Ruowei Jiang, Jeff Houghton, et al.
Cancer|October 23, 2025
A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancerHirva Mamdani, Ryan D Gentzler, Lin Gu, et al.
JCO Precision Oncology|February 9, 2022
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case SeriesMiriam T Jacobs, Nisha A Mohindra, Lindsey Shantzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2017
Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus IpilimumabJohn S Yi, Neal Ready, Patrick Healy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid TumorsSylvie Rottey, Jeffrey Clarke, Kyaw Aung, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Translational Medicine|May 13, 2020
Keynote 42: Pembrolizumab, PD-L1, and where to draw the lineJames Isaacs, Jeffrey Clarke, Neal Ready
Current Oncology Reports|August 3, 2021
Immune Checkpoint Inhibitors in the AgedJames Isaacs, Scott Antonia, Jeffrey Clarke
The American Journal of Case Reports|August 1, 2017
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two CasesArmando Bedoya, Kristen Glisinski, Jeffrey Clarke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2020
<i>APOB</i> Genotypes and <i>CDH13</i> Haplotypes in the Cholesterol-Related Pathway Genes Predict Non-Small Cell Lung Cancer SurvivalWei Deng, Hongliang Liu, Sheng Luo, et al.
Journal of Environmental Radioactivity|May 26, 2024
Neighborhood-level socioeconomic disparities in Radon testing in North Carolina from 2010 to 2020Zhenchun Yang, Lauren Prox, Clare Meernik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2022
Accuracy and clinical relevance of an automated, algorithm-based analysis of facial signs from selfie images of women in the United States of various ages, ancestries and phototypes: A cross-sectional observational studyFrederic Flament, Ruowei Jiang, Jeff Houghton, et al.
Cancer|October 23, 2025
A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancerHirva Mamdani, Ryan D Gentzler, Lin Gu, et al.
JCO Precision Oncology|February 9, 2022
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case SeriesMiriam T Jacobs, Nisha A Mohindra, Lindsey Shantzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2017
Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus IpilimumabJohn S Yi, Neal Ready, Patrick Healy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid TumorsSylvie Rottey, Jeffrey Clarke, Kyaw Aung, et al.
Pageof 2